Last update 16 May 2025

GBV-006

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
GBV 006
Target-
Action
inhibitors
Mechanism
Virus internalization inhibitors, Virus replication inhibitors
Therapeutic Areas
Infectious DiseasesOther Diseases
Active Indication
Hemorrhagic Fever, Ebola
Inactive Indication
COVID-19Hantavirus InfectionsLassa Fever+ [2]
Originator Organization
Stanford UniversityStanford University
Active Organization
Stanford UniversityStanford University
Inactive Organization
Globavir Biosciences, Inc.Globavir Biosciences, Inc.
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with GBV-006
Login to view more data
100 Translational Medicine associated with GBV-006
Login to view more data
100 Patents (Medical) associated with GBV-006
Login to view more data
100 Deals associated with GBV-006
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2
United States
Globavir Biosciences, Inc.Globavir Biosciences, Inc.
11 Apr 2020
Hemorrhagic Fever, EbolaPhase 2
United States
Globavir Biosciences, Inc.Globavir Biosciences, Inc.
15 Aug 2016
Marburg Virus DiseasePreclinical
United States
Globavir Biosciences, Inc.Globavir Biosciences, Inc.
24 Apr 2020
Lassa FeverPreclinical
United States
Globavir Biosciences, Inc.Globavir Biosciences, Inc.
21 Apr 2020
Hantavirus InfectionsPreclinical
United States
Globavir Biosciences, Inc.Globavir Biosciences, Inc.
17 Apr 2020
Respiratory Syncytial Virus InfectionsPreclinical
United States
Globavir Biosciences, Inc.Globavir Biosciences, Inc.
28 Aug 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free